Stress :: Carbon dioxide triggers inborn distress

PLoS ONE publishes a study showing that inhalation of carbon dioxide (CO2) triggers emotional distress and a panic response in healthy individuals. The findings of the study posit panic as an inborn survival-oriented response. The results may be relevant for a better understanding and the further prevention of emotional disorders.

Throat :: Study sheds light on vocal chord dysfunction and treatment

Vocal cord dysfunction (VCD) is the sudden, abnormal narrowing closure of the vocal cords during inhalation causing obstruction of the airflow, and is characterized by a noise that can mimic the sound of wheezing. A VCD attack can easily be mistaken for an asthma attack though it does not respond to asthma medications.

Liver :: Inhaling helps heal liver transplant recipients

A new report from a team of researchers at the University of Washington, Seattle, and the University of Alabama at Birmingham indicates that one of the main complications of liver transplantation can be treated very simply by allowing the transplant recipients to inhale nitric oxide (NO) during the operation in which they received their new liver.

COPD :: GSK receives decision from FDA on Advair 500/50 for COPD

GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in the treatment of patients with chronic obstructive pulmonary disease (COPD).

COPD :: Perforomist inhalation solution effective for COPD, emphysema, chronic bronchitis

Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist? (formoterol fumarate) Inhalation Solution, delivered by nebulization, is an effective and well-tolerated new treatment option for patients suffering from emphysema or chronic bronchitis, otherwise known as Chronic Obstructive Pulmonary Disease (COPD).